1,590
Participants
Start Date
February 18, 2020
Primary Completion Date
October 21, 2022
Study Completion Date
October 31, 2024
PEAR-003A
PEAR-003A delivers CBT-I through a decentralized clinical trial open to participants with chronic insomnia
Pear Therapeutics, Inc., Boston
Lead Sponsor
Pear Therapeutics, Inc.
INDUSTRY